The switch from brand name to generic cholesterol medications that occurred between 2014 and 2018 has saved Medicare billions of dollars, even as the number of people on cholesterol-lowering drugs has increased, UT Southwestern ...
Sep 9, 2020
0
7
For patients, especially those living with chronic conditions, nonadherence to prescription medicines due to cost is a common problem. By not filling prescriptions, skipping doses, delaying refills, or splitting pills, patients ...
Aug 3, 2020
0
2
The NHS could save up to £89 million a year on unnecessary prescriptions for antibiotics, and further its efforts in the fight against antimicrobial resistance—if it was to comprehensively introduce already available and ...
Apr 8, 2020
0
1
Average employer-sponsored insurance spending rose to $5,892 per person in 2018, according to the Health Care Cost Institute annual Health Care Cost and Utilization Report.
Mar 10, 2020
0
0
Seeing a physician or other health specialist for low back and neck pain? You're not alone, according to a new scientific study.
Mar 3, 2020
0
379
Average employer-sponsored insurance (ESI) spending rose to $5,892 per person in 2018, according to the Health Care Cost Institute's annual Health Care Cost and Utilization Report, which analyzes 2.5 billion medical claims ...
Feb 14, 2020
1
2
Seven percent of persons with HIV infection report cost saving-related nonadherence to prescription medication, according to research published in the Dec. 13 issue of the U.S. Centers for Disease Control and Prevention Morbidity ...
Dec 13, 2019
0
1
A glitch in Medicare's revamped prescription plan finder can steer unwitting seniors to coverage that costs much more than they need to pay, according to people who help with sign-ups as well as program experts.
Nov 21, 2019
0
3
The American College of Physicians (ACP) today released new policy papers calling for changes that would mitigate rising prescription drug costs. Policy Recommendations for Public Health Plans to Stem the Escalating Costs ...
Nov 12, 2019
0
1
Biologics used to treat patients can be incredibly expensive, so there was significant hope that biosimilar drugs—which are highly similar to an existing biologic drug on the market—could serve as a less-costly substitute. ...
Nov 4, 2019
0
7
